Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
White vision; This spontaneous case was reported by a non-health professional and describes the occurrence of DYSCHROMATOPSIA (White vision) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSCHROMATOPSIA (White vision). At the time of the report, DYSCHROMATOPSIA (White vision) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications were not provided. The patient experienced issues with white vision and eye sight was recovered. Treatment medications were provided. This case contains information pertaining to the 1st of 2 patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2021-432334 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 29-Dec-2021: Upon internal review on 19-Sep-2025, significant correction was performed to update the case type as valid from invalid and add No patient identifiers classification in the case.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-432334:Patient 2